相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
miR-21 inhibition reverses doxorubicin-resistance and inhibits PC3 human prostate cancer cells proliferation
Weichong Zhao et al.
ANDROLOGIA (2021)
Role of noncoding RNA in drug resistance of prostate cancer
Lifeng Ding et al.
CELL DEATH & DISEASE (2021)
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
Margherita Ratti et al.
TARGETED ONCOLOGY (2020)
Therapeutic efficacy of modified anti-miR21 in metastatic prostate cancer
Kyungmin Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process
Giovanni Barillari
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
Pernelle Lavaud et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Upregulated Wnt-11 and miR-21 Expression Trigger Epithelial Mesenchymal Transition in Aggressive Prostate Cancer Cells
Elif Damla Arisan et al.
BIOLOGY-BASEL (2020)
Circulating microRNAs in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy
Alicia C. McDonald et al.
PROSTATE (2019)
CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
Eva Lentsch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression
Adam Olson et al.
PLOS GENETICS (2019)
CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model
Ruisong Ye et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing
Teng Fei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer
Akira Kurozumi et al.
CANCER SCIENCE (2016)
A microRNA code for prostate cancer metastasis
D. Bonci et al.
ONCOGENE (2016)
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
Tang Liu et al.
CANCER LETTERS (2016)
Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer
Katia R. M. Leite et al.
JOURNAL OF CANCER (2015)
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Yixuan Gong et al.
CANCERS (2014)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition
V. Coppola et al.
ONCOGENE (2013)
MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer
Sabrina Thalita Reis et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2011)
miR-21: an oncomir on strike in prostate cancer
Marco Folini et al.
MOLECULAR CANCER (2010)
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
Tao Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
分享论文
